Key Points
- Chemed director Andrea Lindell sold 1,347 shares on June 9 at an average price of $447.33, totaling about $602,554. After the sale, she still owned 4,578 shares.
- Chemed’s stock was down 2.6% and recently traded at $434.63, with a market cap of $5.77 billion and a 12-month range of $365.20 to $562.77.
- The company beat quarterly EPS expectations with $5.65 per share versus $5.30 expected, and it also announced a quarterly dividend of $0.60 per share, payable June 16.
Chemed Corporation (NYSE:CHE - Get Free Report) Director Andrea Lindell sold 1,347 shares of the business's stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the transaction, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Chemed Trading Down 2.6%
Chemed stock opened at $434.63 on Thursday. The company's fifty day simple moving average is $413.56 and its 200-day simple moving average is $424.69. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. Chemed Corporation has a 12 month low of $365.20 and a 12 month high of $562.77. The stock has a market cap of $5.77 billion, a P/E ratio of 23.69, a P/E/G ratio of 1.67 and a beta of 0.54.
Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating the consensus estimate of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business had revenue of $657.51 million for the quarter, compared to analysts' expectations of $659.22 million. During the same period in the previous year, the company posted $5.63 EPS. Chemed's revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, sell-side analysts forecast that Chemed Corporation will post 22.3 EPS for the current fiscal year.
Chemed Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th will be issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Thursday, May 28th. Chemed's payout ratio is currently 13.08%.
Institutional Investors Weigh In On Chemed
A number of hedge funds have recently bought and sold shares of CHE. Northwestern Mutual Wealth Management Co. boosted its holdings in Chemed by 2,444,879.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company's stock valued at $2,374,667,000 after acquiring an additional 5,549,876 shares during the period. JPMorgan Chase & Co. boosted its holdings in Chemed by 122.7% during the third quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company's stock valued at $223,856,000 after acquiring an additional 275,423 shares during the period. Norges Bank bought a new stake in Chemed during the fourth quarter valued at about $76,067,000. AQR Capital Management LLC boosted its holdings in Chemed by 89.2% during the fourth quarter. AQR Capital Management LLC now owns 325,579 shares of the company's stock valued at $139,302,000 after acquiring an additional 153,469 shares during the period. Finally, Victory Capital Management Inc. boosted its holdings in Chemed by 1,260.2% during the fourth quarter. Victory Capital Management Inc. now owns 117,685 shares of the company's stock valued at $50,353,000 after acquiring an additional 109,033 shares during the period. 95.85% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
CHE has been the subject of a number of recent research reports. Oppenheimer decreased their price objective on shares of Chemed from $580.00 to $500.00 and set an "outperform" rating for the company in a report on Friday, February 27th. Zacks Research upgraded shares of Chemed from a "strong sell" rating to a "hold" rating in a report on Monday, April 27th. Royal Bank Of Canada upped their price objective on shares of Chemed from $422.00 to $436.00 and gave the stock a "sector perform" rating in a report on Monday, April 27th. Wall Street Zen cut shares of Chemed from a "buy" rating to a "hold" rating in a report on Monday. Finally, Weiss Ratings upgraded shares of Chemed from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, April 29th. Two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $501.50.
View Our Latest Analysis on Chemed
Chemed Company Profile
(
Get Free Report)
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
